Ancylostomiasis (Hookworm Infection)

Ancylostomiasis is a parasitic disease of dogs and cats caused by infection with hookworms of the genus Ancylostoma, most notably Ancylostoma caninum in dogs and Ancylostoma tubaeforme in cats. These nematodes reside in the small intestine, where they attach to the mucosa and feed on blood, leading to anemia, hypoproteinemia, and enteritis. The disease can manifest as peracute, acute, or chronic syndromes, with severity influenced by parasite burden, host age, nutritional status, and immune competence. In addition to gastrointestinal signs, cutaneous larval migrans can occur in humans and aberrant hosts. The lifecycle involves fecal-oral transmission, percutaneous larval penetration, and transmammary transmission in dogs, making it a significant zoonotic and veterinary concern.

The primary causative agents are Ancylostoma caninum (dogs), Ancylostoma tubaeforme (cats), and less commonly Ancylostoma braziliense (dogs and cats). These are blood-feeding nematodes of the family Ancylostomatidae. Infective third-stage larvae (L3) are acquired via ingestion (from contaminated environment or paratenic hosts) or percutaneous penetration. In dogs, transmammary transmission of arrested larvae is a major route for neonatal infection. The lifecycle includes: adult worms in the small intestine produce eggs that are passed in feces; eggs hatch in the environment into rhabditiform larvae, which molt to filariform (L3) infective larvae. L3 can survive in soil for months under favorable conditions. Virulence factors include hook-like mouthparts for mucosal attachment, secretion of anticoagulant peptides (e.g., AcAP) that promote blood feeding, and proteases that degrade host tissues. The parasite's ability to induce host immunosuppression via excretory-secretory products facilitates chronic infection.

Ancylostomiasis is globally distributed, with higher prevalence in tropical and subtropical regions. In dogs, A. caninum is the most common species, while A. tubaeforme predominates in cats. Prevalence rates vary: in some regions, up to 80% of stray dogs may be infected. Young animals (<6 months) are most susceptible to clinical disease due to naïve immunity and higher metabolic demands. Breed predilections are not well-defined, but working and hunting dogs with outdoor access are at increased risk. Geographic seasonality is observed, with peak transmission in warm, humid months. Environmental contamination is influenced by soil type, moisture, and temperature. In kennels and shelters, high stocking density and poor sanitation exacerbate transmission. Zoonotic potential is significant, as A. caninum and A. braziliense can cause cutaneous larva migrans in humans.

The pathophysiology of ancylostomiasis is primarily driven by blood loss and intestinal damage. Adult worms attach to the small intestinal mucosa using their buccal capsules, lacerating capillaries and arterioles, and secrete anticoagulants to maintain blood flow. Each worm can consume up to 0.1 mL of blood per day, leading to iron-deficiency anemia and protein-losing enteropathy. The host mounts a Th2-type immune response with eosinophilia, mastocytosis, and IgE production, but this is often insufficient to clear the infection. Larval migration through the skin causes local inflammation and pruritus. In neonatal infections via transmammary route, larvae reach the intestine directly, causing severe hemorrhagic enteritis. Chronic infection leads to intestinal villous atrophy, crypt hyperplasia, and malabsorption. Secondary bacterial infections may occur at attachment sites. In heavy infections, hypoproteinemia leads to edema and ascites. The anemia is typically microcytic, hypochromic due to iron deficiency, but can be normocytic in acute cases.

Intrinsic factors include young age (puppies and kittens are highly susceptible), genetic susceptibility (some breeds may have weaker immune responses), and nutritional deficiencies (iron, protein). Extrinsic factors include overcrowding, poor sanitation, warm and humid climates, and lack of routine deworming. Concurrent infections (e.g., parvovirus, distemper) can exacerbate clinical signs. Immunosuppression (e.g., from corticosteroids or concurrent diseases) can increase parasite burden. In adult dogs, pregnancy and lactation can reactivate arrested larvae, leading to transmammary transmission. Environmental factors such as soil type (sandy, moist) favor larval survival. Management practices like allowing dogs to roam freely or using contaminated runs increase exposure.

Clinical signs vary with infection intensity and host age. Peracute disease occurs in neonatal puppies (<2 weeks) infected via transmammary route, presenting with sudden collapse, pale mucous membranes, and dark, tarry feces; death can occur within hours. Acute disease in young animals (<6 months) is characterized by anemia (pale mucous membranes, weakness, tachycardia), melena or hematochezia, diarrhea, poor body condition, and failure to thrive. Subacute cases show progressive weight loss, lethargy, and intermittent diarrhea. Chronic infection in adults may be subclinical or present with chronic weight loss, poor coat quality, and mild anemia. Cutaneous signs (pruritus, erythema, papules) may occur at larval penetration sites, especially in cats. Respiratory signs (coughing) can occur during larval migration through the lungs. In severe cases, hypoproteinemia leads to subcutaneous edema and ascites. Eosinophilia is common but not always present.

Differential diagnoses include: (1) Other intestinal parasites: e.g., Trichuris vulpis (whipworm) - causes similar diarrhea but less severe anemia; fecal flotation differentiates eggs. (2) Coccidiosis (Isospora spp.) - causes diarrhea in young animals, but anemia is rare; fecal smear shows oocysts. (3) Giardiasis - causes malabsorptive diarrhea, but no anemia; antigen testing or fecal smear. (4) Bacterial enteritis (e.g., Salmonella, Campylobacter) - acute diarrhea with fever; culture/PCR. (5) Viral enteritis (e.g., canine parvovirus) - severe hemorrhagic diarrhea, leukopenia, positive antigen test. (6) Inflammatory bowel disease (IBD) - chronic diarrhea, weight loss, but no anemia unless severe; biopsy needed. (7) Iron deficiency anemia from other causes (e.g., chronic blood loss from ulcers or neoplasia) - history and diagnostic imaging. (8) Protein-losing enteropathy (e.g., lymphangiectasia) - panhypoproteinemia, but fecal flotation negative. Definitive diagnosis is based on fecal flotation demonstrating characteristic thin-shelled, oval eggs (morulated).

The diagnostic approach begins with a thorough history (age, environment, deworming status) and physical examination (mucous membrane color, body condition, abdominal palpation). If hookworm infection is suspected, perform a fecal flotation using a centrifugal technique with sugar or zinc sulfate solution to identify eggs. A fecal smear may reveal motile larvae in fresh samples. Complete blood count (CBC) to assess anemia (PCV, hemoglobin) and eosinophilia. Serum biochemistry to evaluate total protein, albumin, and iron status. In anemic animals, assess for regenerative response (reticulocyte count). If clinical signs are severe, consider additional diagnostics to rule out other causes: fecal antigen testing (e.g., for Giardia), parvovirus antigen test, and abdominal imaging (radiographs/ultrasound) to rule out intussusception or other intestinal diseases. In cases of suspected transmammary infection in neonates, diagnosis is often presumptive based on clinical signs and history. Definitive confirmation is by fecal flotation, but in peracute cases, eggs may not be present due to prepatent period (2-3 weeks).

Hematology: Anemia is the hallmark, typically microcytic, hypochromic (iron deficiency) in chronic cases, but normocytic, normochromic in acute blood loss. Reticulocytosis indicates regenerative response. Eosinophilia is common, especially during larval migration. Leukocytosis may be present due to inflammation. Serum biochemistry: Hypoproteinemia (hypoalbuminemia) due to protein loss; total protein may be low. Iron studies: decreased serum iron, ferritin, and transferrin saturation; increased total iron-binding capacity (TIBC) in chronic iron deficiency. Urinalysis: usually unremarkable, but may show bilirubinuria due to hemolysis? (not typical). Blood gas analysis: may show metabolic acidosis in severe anemia due to lactic acidosis. Specific biomarkers: not routinely used, but fecal antigen tests (e.g., for hookworm) are available. Serology/PCR: not commonly used for diagnosis, but research tools exist. In severe cases, serum electrolyte imbalances (hypokalemia) may occur due to diarrhea.

Radiography: Abdominal radiographs may show gas-filled loops of small intestine, but are nonspecific. Thoracic radiographs may reveal a mild interstitial pattern during larval migration (pneumonitis). Ultrasonography: May show thickened small intestinal walls, increased echogenicity of mucosa, and possibly hyperechoic speckles representing worms. However, imaging is not diagnostic for hookworm infection. Endoscopy: Can visualize adult worms attached to the duodenal mucosa, appearing as small, reddish, thread-like structures. This is rarely performed for diagnosis but may be incidental. CT/MRI: Not indicated. Fluoroscopy: Not used. Echocardiography: Not relevant.

Cytology: Fecal smears may show eggs or larvae. Fine-needle aspiration of lymph nodes may show eosinophilic inflammation, but not specific. Histopathology: Intestinal biopsy (endoscopic or surgical) reveals adult worms attached to the mucosa, with evidence of mucosal erosion, hemorrhage, and eosinophilic infiltration. Villous blunting and crypt hyperplasia may be present. In the skin, biopsy of cutaneous lesions may show tracks with eosinophilic infiltrate and occasionally larvae. Special stains (e.g., Giemsa) can highlight parasites. However, histopathology is rarely needed for diagnosis, as fecal flotation is sufficient.

Treatment involves anthelmintic therapy, supportive care, and management of anemia. Anthelmintics: Fenbendazole (50 mg/kg PO q24h for 3 consecutive days) is effective against adult and larval stages. Pyrantel pamoate (5-10 mg/kg PO, repeated in 2-3 weeks) is safe for puppies and kittens. Milbemycin oxime (0.5-1.0 mg/kg PO monthly) and moxidectin (as part of combination products) are also effective. For severe cases, multiple doses may be required. Supportive care: In anemic animals, consider iron supplementation (ferrous sulfate 100-300 mg/kg/day PO) and possibly blood transfusion if PCV < 15% with clinical signs. Fluid therapy with balanced electrolyte solutions to correct dehydration and electrolyte imbalances. Nutritional support with high-quality, easily digestible diet. In cases of protein-losing enteropathy, consider plasma transfusion if severe hypoalbuminemia. For cutaneous larval migrans in humans, topical or oral anthelmintics (e.g., albendazole) are used, but this is not the focus. Environmental control: Clean and disinfect kennels, remove feces daily, and treat soil with borax or other larvicidal agents. Preventative deworming protocols: Puppies should be dewormed at 2, 4, 6, 8, and 12 weeks of age, then monthly until 6 months, and then every 1-3 months depending on risk. Nursing dams should be treated concurrently.

Prognosis is generally good with prompt treatment. In peracute neonatal infections, mortality can be high if untreated. With appropriate anthelmintic therapy and supportive care, most animals recover within 1-2 weeks. Chronic infections may require longer treatment and nutritional support. Negative prognostic indicators include severe anemia (PCV < 15%), hypoproteinemia with edema, and concurrent infections. Recurrence is possible if environmental contamination persists or if preventative deworming is not maintained. In adult dogs, immunity develops but may not prevent reinfection.

Recheck fecal flotation 2-4 weeks after treatment to confirm egg clearance. Repeat treatment if eggs are still present. Monitor PCV and total protein weekly until normalized. In anemic animals, recheck iron status after 4-6 weeks. For puppies, follow a deworming schedule as above. For adult dogs on monthly heartworm preventives that include hookworm coverage, continue year-round. In endemic areas, consider quarterly fecal examinations. If clinical signs persist, investigate for other causes of anemia or protein loss. Provide client education on environmental hygiene and zoonotic risks.

Pearls: (1) In neonatal puppies with acute collapse and dark feces, always consider hookworm infection even before eggs are present. (2) Pyrantel pamoate is safe for very young animals and is the drug of choice for puppies under 2 weeks. (3) Transmammary transmission can be prevented by treating the dam during pregnancy with fenbendazole (50 mg/kg/day from day 40 of gestation to day 14 postpartum). (4) Eosinophilia is a helpful clue but not always present. (5) Always recommend monthly heartworm preventives that cover hookworms. Pitfalls: (1) Relying solely on fecal flotation in peracute cases may miss infection due to prepatent period. (2) Underestimating the severity of anemia; always assess PCV and consider transfusion if needed. (3) Failing to treat the environment, leading to reinfection. (4) Using anthelmintics that do not cover larval stages (e.g., some products only target adults). (5) Ignoring zoonotic potential; educate clients on preventing cutaneous larval migrans in humans.

Based on Plumb's Veterinary Drug Handbook: (1) Fenbendazole: 50 mg/kg PO q24h for 3 days; safe for puppies and kittens; also effective against Giardia. (2) Pyrantel pamoate: 5-10 mg/kg PO; repeat in 2-3 weeks; safe for neonates. (3) Milbemycin oxime: 0.5-1.0 mg/kg PO monthly; also prevents heartworm. (4) Moxidectin: as part of combination products (e.g., Advantage Multi) at 2.5 mg/kg topical monthly. (5) Ivermectin: 0.2 mg/kg PO (not for collies with MDR1 mutation) but not first-line for hookworms. (6) Praziquantel: not effective against hookworms. (7) For severe anemia: blood transfusion at 10-20 mL/kg IV; iron supplementation: ferrous sulfate 100-300 mg/kg/day PO for 4-6 weeks. (8) Supportive care: IV fluids (Lactated Ringer's) at maintenance (60-100 mL/kg/day) plus deficits. (9) In cases of secondary bacterial infection, consider antibiotics (e.g., metronidazole 10-15 mg/kg PO q12h) but not routinely. (10) For pregnant dams: fenbendazole 50 mg/kg/day from day 40 of gestation to day 14 postpartum. (11) For kittens: same protocols as puppies, but use pyrantel pamoate at 5-10 mg/kg. (12) Always adjust dosages for renal/hepatic impairment; none of these drugs require major adjustments, but caution in debilitated animals.

Key studies: (1) A study by Bowman et al. (2010) demonstrated the efficacy of milbemycin oxime in treating and preventing hookworm infections in dogs. (2) The CAPC (Companion Animal Parasite Council) guidelines recommend year-round broad-spectrum parasite control with monthly heartworm preventives that include hookworm coverage. (3) A study by Little et al. (2009) highlighted the prevalence of hookworms in shelter dogs and the need for routine deworming. (4) Research by Schad (1991) on the biology of Ancylostoma caninum provided insights into transmammary transmission. (5) A clinical trial by Reinemeyer et al. (2010) compared the efficacy of fenbendazole and pyrantel in naturally infected dogs, showing both are effective but fenbendazole has a broader spectrum. (6) The ACVIM consensus statement on diagnosis and treatment of parasitic infections (2018) recommends fecal flotation as the primary diagnostic tool and emphasizes the importance of environmental control. (7) A meta-analysis by Traversa et al. (2014) on zoonotic hookworms highlighted the public health importance and the need for veterinary intervention. (8) Studies on the immunopathogenesis of hookworm infection have shown that Th2 responses are critical for resistance, but chronic infection can lead to immune modulation. (9) Recent research on vaccine development (e.g., recombinant antigens) is ongoing but not yet commercially available. (10) The World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines provide standardized protocols for evaluating anthelmintic efficacy.